These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9304765)

  • 1. A graphical assessment of the potential impact of losses to follow-up on the validity of study results. The Terry Beirn Community Programs for Clinical Research on AIDS.
    Matts JP; Launer CA; Nelson ET; Miller C; Dain B
    Stat Med; 1997 Sep; 16(17):1943-54. PubMed ID: 9304765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations in choice of a clinical endpoint for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
    Neaton JD; Wentworth DN; Rhame F; Hogan C; Abrams DI; Deyton L
    Stat Med; 1994 Oct 15-30; 13(19-20):2107-25. PubMed ID: 7846414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community advisory boards: their role in AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS.
    Cox LE; Rouff JR; Svendsen KH; Markowitz M; Abrams DI
    Health Soc Work; 1998 Nov; 23(4):290-7. PubMed ID: 9834882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials.
    Hedden SL; Woolson RF; Carter RE; Palesch Y; Upadhyaya HP; Malcolm RJ
    J Subst Abuse Treat; 2009 Jul; 37(1):54-63. PubMed ID: 19008067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with a cross-study endpoint review committee for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS.
    Green LA; Rhame FS; Price RW; Perlman DC; Capps LG; Sampson JH; Deyton LR; Schnittman SM; Fisher EJ; Bartsch GE; Krum EA; Neaton JD
    AIDS; 1998 Oct; 12(15):1983-90. PubMed ID: 9814866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dropouts on sample size estimates for test on trends across repeated measurements.
    Ahn C; Jung SH
    J Biopharm Stat; 2005; 15(1):33-41. PubMed ID: 15702603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical approach to adjusting for attrition bias in HIV clinical trials with serial marker responses.
    Cozzi Lepri A; Smith GD; Mocroft A; Sabin CA; Morris RW; Phillips AN
    AIDS; 1998 Jul; 12(10):1155-61. PubMed ID: 9677164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of GEE procedures for sample size calculations in repeated measures experiments.
    Rochon J
    Stat Med; 1998 Jul; 17(14):1643-58. PubMed ID: 9699236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG; Siu CO
    Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract]   [Full Text] [Related]  

  • 10. Statistical outcome of random versus selected withdrawal of dental implants.
    Herrrmann I; Lekholm U; Holm S
    Int J Prosthodont; 2003; 16(1):25-30. PubMed ID: 12675451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reading reports of clinical trial results.
    Kane JM
    J Clin Psychiatry; 2005 May; 66(5):653. PubMed ID: 15889955
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimating sample size for tests on trends across repeated measurements with missing data based on the interaction term in a mixed model.
    Yi Q; Panzarella T
    Control Clin Trials; 2002 Oct; 23(5):481-96. PubMed ID: 12392862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bias correction in testing treatment efficacy under informative dropout in clinical trials.
    Kong F; Chen YF; Jin K
    J Biopharm Stat; 2009 Nov; 19(6):980-1000. PubMed ID: 20183460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical primer: sample size and power calculations-why, when and how?
    Hickey GL; Grant SW; Dunning J; Siepe M
    Eur J Cardiothorac Surg; 2018 Jul; 54(1):4-9. PubMed ID: 29757369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection bias in observational and experimental studies.
    Ellenberg JH
    Stat Med; 1994 Mar 15-Apr 15; 13(5-7):557-67. PubMed ID: 8023035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A median-based test under informative dropout: the one-sample case.
    Liang WM; Brown MB
    Control Clin Trials; 1997 Oct; 18(5):445-59. PubMed ID: 9315427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size calculation for count data in comparative clinical trials with nonuniform patient accrual and early dropout.
    Li H; Wang L; Wei L; Quan H
    J Biopharm Stat; 2015; 25(1):1-15. PubMed ID: 24836982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The performance of sample selection estimators to control for attrition bias.
    Grasdal A
    Health Econ; 2001 Jul; 10(5):385-98. PubMed ID: 11466801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stopping clinical trials early for benefit: impact on estimation.
    Freidlin B; Korn EL
    Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrected profile likelihood confidence interval for binomial paired incomplete data.
    Pradhan V; Menon S; Das U
    Pharm Stat; 2013; 12(1):48-58. PubMed ID: 23296487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.